These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17452827)

  • 1. An objective assessment of botulinum toxin A effect on superficial skin texture.
    Dessy LA; Mazzocchi M; Rubino C; Mazzarello V; Spissu N; Scuderi N
    Ann Plast Surg; 2007 May; 58(5):469-73. PubMed ID: 17452827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin A: a 9-month clinical and 3D in vivo profilometric crow's feet wrinkle formation study.
    Levy JL; Servant JJ; Jouve E
    J Cosmet Laser Ther; 2004 May; 6(1):16-20. PubMed ID: 15370408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxins for facial wrinkles: beyond glabellar lines.
    Dayan SH; Maas CS
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):41-9, vi. PubMed ID: 17317554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of the ageing eyebrow and forehead: an objective dose-response study with botulinum toxin.
    Levy JL; Pons F; Jouve E
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):711-6. PubMed ID: 16836501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of botulinum toxin therapy in otorhinolaryngology: experience from 1,000 treatments.
    Helmstaedter V; Wittekindt C; Huttenbrink KB; Guntinas-Lichius O
    Laryngoscope; 2008 May; 118(5):790-6. PubMed ID: 18300708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?
    Carruthers A; Carruthers J; Cohen J
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S97-104. PubMed ID: 17241422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology.
    Kaltreider SA; Kennedy RH; Woog JJ; Bradley EA; Custer PL; Meyer DR; ;
    Ophthalmology; 2005 Jun; 112(6):1159-67. PubMed ID: 15936443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eyebrow height after botulinum toxin type A to the glabella.
    Carruthers A; Carruthers J
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S26-31. PubMed ID: 17241411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in botulinum toxins: time to end the confusion.
    Brin MF; Tan K; Gallagher C
    J Cosmet Laser Ther; 2009 Sep; 11(3):180-1. PubMed ID: 19626521
    [No Abstract]   [Full Text] [Related]  

  • 11. Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin.
    Swartling C; Naver H; Pihl-Lundin I; Hagforsen E; Vahlquist A
    J Am Acad Dermatol; 2004 Nov; 51(5):739-45. PubMed ID: 15523352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core curriculum for plastic surgical nursing: botulinum toxin type A for facial aesthetics.
    Weber BB
    Plast Surg Nurs; 2008; 28(3):136-41. PubMed ID: 18794738
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of clostridium botulinum: a neurotoxin in clinical dermatology.
    Matarasso SL
    West J Med; 1998 Oct; 169(4):226. PubMed ID: 9795588
    [No Abstract]   [Full Text] [Related]  

  • 14. The botox boom.
    Noonan D; Adler J
    Newsweek; 2002 May; 139(19):50-6, 58. PubMed ID: 12037916
    [No Abstract]   [Full Text] [Related]  

  • 15. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
    Carroll A; Barnes M; Comiskey C
    Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
    Sahai A; Dowson C; Khan MS; Dasgupta P
    BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type A in the treatment of lateral orbital rhytides.
    Carruthers A; Bogle M; Carruthers JD; Dover JS; Arndt KA; Hsu TS; Poirier J
    Dermatol Surg; 2007 May; 33(5):567-71. PubMed ID: 17451579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A.
    Chang SP; Tsai HH; Chen WY; Lee WR; Chen PL; Tsai TH
    Int J Dermatol; 2008 Dec; 47(12):1287-94. PubMed ID: 19126019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vivo analysis of the effect and duration of treatment with botulinum toxin type A using digital image speckle correlation.
    Bhatnagar D; Conkling N; Rafailovich M; Phillips BT; Bui DT; Khan SU; Dagum AB
    Skin Res Technol; 2013 Aug; 19(3):220-9. PubMed ID: 23565582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of the efficacy of botulinum toxin type A by digital image analysis.
    Heckmann M; Schön-Hupka G
    J Am Acad Dermatol; 2001 Oct; 45(4):508-14. PubMed ID: 11568739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.